Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Role of Stat3 in regulating p53 expression and function.

Guilian Niu1, Kenneth L Wright, Yihong Ma

  • 1Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

Molecular and Cellular Biology
|August 19, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiation immunodynamics: association of baseline and longitudinal cytokine levels during radiotherapy in glioblastoma with survival.

Journal of neuro-oncology·2026
Same author

The ionotropic AMPA receptor contributes to autoimmunity via altered regulatory T cell differentiation.

iScience·2026
Same author

Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signaling.

Science signaling·2025
Same author

Correction: Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Deciphering Cell Fate and Clonal Dynamics via Integrative Single-Cell Lineage Modeling.

Research square·2025
Same author

Dual checkpoint blockade of glioblastoma with Anti-PD-1 and Anti-LAG-3 promotes expansion of tumor-reactive T cell clones along a unique pathway of differentiation.

bioRxiv : the preprint server for biology·2025

Oncogenic signaling pathways inhibit tumor suppressor p53 transcription via Stat3. Blocking Stat3 reactivates p53, promoting cancer cell apoptosis and offering a novel therapeutic strategy for many cancers.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Signal Transduction

Background:

  • Loss of p53 tumor suppressor function is critical in cancer development.
  • Many cancers exhibit reduced p53 expression without direct p53 mutations, suggesting alternative inactivation mechanisms.

Purpose of the Study:

  • To elucidate mechanisms that disable p53 during early cancer development.
  • To investigate the role of Signal Transducer and Activator of Transcription 3 (Stat3) in p53 regulation.
  • To explore Stat3 as a therapeutic target for p53 reactivation in cancer.

Main Methods:

  • Investigated Stat3 binding to the p53 promoter in vitro and in vivo.
  • Utilized site-specific mutations in the p53 promoter to assess Stat3 binding effects.
  • Examined the impact of Stat3 inhibition on p53 expression and cancer cell apoptosis.

Related Experiment Videos

Main Results:

  • Oncogenic signaling pathways, via Stat3, inhibit p53 gene transcription.
  • Stat3 binds to the p53 promoter, and mutations in this site reduce Stat3-mediated inhibition.
  • Blocking Stat3 in cancer cells restores p53 expression and induces apoptosis.

Conclusions:

  • Stat3 acts as a key repressor of p53 expression in the context of oncogenic signaling.
  • Stat3 is a promising therapeutic target for reactivating p53 in cancers lacking p53 mutations.
  • Targeting Stat3 offers a novel strategy for cancer therapy by restoring tumor suppressor function.